95% CI, 0.630.85), with no significant interaction by sex ( Regarding safety, women experienced a higher incidence of genital infections while on SGLT-2 inhibitors, likely due to anatomical predisposition, which may impact treatment adherence ( For GLP-1 receptor agonists, the REWIND trial demonstrated a reduction in cardiovascular events with dulaglutide, with a trend toward greater benefit in women, although statistical significance was not achieved (RR 0.85
Can LDN (low dose naltrexone) Help with Weight Loss
N Engl J Med 385:503515 Davies MJ, Bergenstal R, Bode B et al (2015) Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE diabetes randomized clinical trial
In the PANTHEON study, moderate COPD patients gained more improvement than severe COPD patients, suggesting that long-term and regular treatment is critical to gaining benefit in the early stages of COPD
What makes Epitalon intriguing in the oncology space is not that it targets tumors directly, but that it appears to stabilize genomic integrity that allows cancer to flourish in the first place
D., Lucas W
